$MRNS MARINUS PHARMACEUTICALS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MARINUS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in MARINUS PHARMACEUTICALS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
MARINUS PHARMACEUTICALS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Austin Charles | Director | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 4,530,335 | 5,481,705 | shares bought: 0 / shares sold: -1,272,547 | STRONG SELL | Dec 19 2017 | |
| Bloch Stephen M | Director | 39,550 | 47,856 | Sep 28 2015 | |||
| Bloch Stephen M | Director | 0 | 0 | Oct 02 2014 | |||
| Braunstein Scott | Chief Executive Officer | 100,000 | 121,000 | shares bought: 100,000 / shares sold: 0 | BUY | Jan 19 2021 | 17 months ago |
| Canaan VII L P | 10% Owner | 1,870,733 | 2,263,587 | shares bought: 0 / shares sold: -610,616 | STRONG SELL | Aug 09 2016 | |
| Canaan VII L P | Director | 2,461,398 | 2,978,292 | Aug 06 2014 | |||
| Canaan VII LP | Director | 0 | 0 | Oct 02 2014 | |||
| Carrazana Enrique J. | Director | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| Carrazana Enrique J. | Director | 0 | 0 | Oct 02 2014 | |||
| Cashman Christopher Michael | CEO | 271,423 | 328,422 | shares bought: 31,662 / shares sold: -27,274 | BUY | Mar 20 2019 | |
| Cashman Christopher Michael | PRESIDENT AND CEO | 80,830 | 97,804 | Oct 09 2014 | |||
| Cashman Christopher Michael | President and CEO | 0 | 0 | Dec 23 2014 | |||
| Domain Partners VI, L.P. | 10% Owner | 2,476,886 | 2,997,032 | Aug 07 2014 | |||
| DOUGHERTY MICHAEL R | Director | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| DP VI Associates, L.P. | 10% Owner | 17,000 | 20,570 | Aug 07 2014 | |||
| Ezickson Elan | Director | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| Farfel Gail M | Chief Clinical Dev & Reg Offic | 0 | 0 | Apr 23 2015 | |||
| Farfel Gail M | Chief Clinical Dev & Reg | 0 | 0 | Dec 23 2014 | |||
| Fischer Seth H.Z. | Director | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| Gopka Anton | Director | 0 | 0 | Oct 02 2014 | |||
| Hulihan Joseph | Chief Medical Officer | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| Lorianne Masuoka K. | Chief Medical Officer | 0 | 0 | Aug 23 2019 | |||
| MANNING MARTHA E | VP Gen Counsel and Corp Sec. | 0 | 0 | Jan 19 2021 | 17 months ago | ||
| MAYLEBEN TIMOTHY M | Director | 42,550 | 51,486 | Jan 19 2021 | 17 months ago | ||
| MAYLEBEN TIMOTHY M | Director | 0 | 0 | Oct 02 2014 | |||
| Mehra Anand | 10% Owner | 1,134,851 | 1,373,170 | shares bought: 0 / shares sold: -750,683 | STRONG SELL | Oct 24 2016 | |
| Mehra Anand | Director | 27,998 | 33,878 | Oct 01 2014 | |||
| Nochur Sara | Director | 0 | 0 | Mar 24 2021 | 15 months ago | ||
| Patroneva Albena | Chief Medical Officer | 0 | 0 | Aug 05 2016 | |||
| Pfanstiel Steven | CFO | 0 | 0 | Apr 13 2021 | 15 months ago | ||
| Shepard Jay | Director | 0 | 0 | Jan 19 2017 | |||
| Shepard Jay | Director | 0 | 0 | Oct 02 2014 | |||
| Smith Edward F | CFO | 17,717 | 21,438 | shares bought: 0 / shares sold: -35,083 | STRONG SELL | Feb 03 2020 | |
| Smith Edward F | CFO | 0 | 0 | Dec 23 2014 | |||
| VITULLO NICOLE | Director | 0 | 0 | shares bought: 20,609 / shares sold: -645,175 | STRONG SELL | Mar 16 2021 | 16 months ago |
| VITULLO NICOLE | Director | 0 | 0 | Oct 01 2014 |